Epiliquid
EPIliquid is a biotechnology startup focused on making early cancer detection accessible to all. They have developed a liquid biopsy platform that analyzes blood samples for specific biomarkers, utilizing a bioinformatic framework powered by Big Data and Artificial Intelligence. Their solution is designed to be effective, affordable, simple to use with widely available equipment, and minimally invasive. The company aims to improve public health by democratizing early cancer detection, thereby increasing survival rates and reducing the global economic impact of cancer. Their technology is described as proprietary and allows for the detection of multiple biomarkers in a single reaction.
Epiliquid
EPIliquid is a biotechnology startup focused on making early cancer detection accessible to all. They have developed a liquid biopsy platform that analyzes blood samples for specific biomarkers, utilizing a bioinformatic framework powered by Big Data and Artificial Intelligence. Their solution is designed to be effective, affordable, simple to use with widely available equipment, and minimally invasive. The company aims to improve public health by democratizing early cancer detection, thereby increasing survival rates and reducing the global economic impact of cancer. Their technology is described as proprietary and allows for the detection of multiple biomarkers in a single reaction.